We are live on ! Find out more
EDIT icon

Editas Medicine

264 hedge funds and large institutions have $591M invested in Editas Medicine in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 75 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

27% more call options, than puts

Call options by funds: $23.8M | Put options by funds: $18.6M

5% more capital invested

Capital invested by funds: $561M → $591M (+$30.3M)

3% more funds holding

Funds holding: 256264 (+8)

1.05% more ownership

Funds ownership: 69.17%70.22% (+1%)

3% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 75

Holders
264
Holders Change
+8
Holders Change %
+3.13%
% of All Funds
4.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
73
Reduced
75
Closed
28
Calls
$23.8M
Puts
$18.6M
Net Calls
+$5.13M
Net Calls Change
+$6.09M
Name Holding Trade Value Shares
Change
Change in
Stake
VF
101
Virtu Financial
New York
$380K -$11.8K -757 -2%
PNC Financial Services Group
102
PNC Financial Services Group
Pennsylvania
$379K +$1.95K +125 +0.4%
EFM
103
E Fund Management
China
$368K -$144K -9,249 -24%
State Board of Administration of Florida Retirement System
104
State Board of Administration of Florida Retirement System
Florida
$365K
BCM
105
Bayesian Capital Management
New York
$353K +$91.9K +5,900 +26%
WM
106
WS Management
Florida
$352K
CAM
107
ClariVest Asset Management
California
$348K -$1.22K -78 -0.3%
APP
108
Alpha Paradigm Partners
Illinois
$348K +$443K +28,447 New
Janus Henderson Group
109
Janus Henderson Group
United Kingdom
$334K +$214K +13,720 +100%
Manulife (Manufacturers Life Insurance)
110
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$332K -$10.6K -680 -2%
QT
111
Quantamental Technologies
New York
$328K +$418K +26,796 New
VOYA Investment Management
112
VOYA Investment Management
Georgia
$326K
KOCAA
113
Knights of Columbus Asset Advisors
Connecticut
$324K +$51.1K +3,277 +14%
TRCT
114
Tower Research Capital (TRC)
New York
$300K -$319K -20,504 -46%
CRC
115
Curi RMB Capital
Illinois
$300K
NIA
116
NIA Impact Advisors
California
$299K -$1.1M -70,284 -74%
SG Americas Securities
117
SG Americas Securities
New York
$299K -$412K -26,447 -52%
EWM
118
Elmwood Wealth Management
California
$295K -$250K -16,025 -40%
Mitsubishi UFJ Asset Management
119
Mitsubishi UFJ Asset Management
Japan
$282K +$5.72K +367 +2%
SEC
120
Seven Eight Capital
New York
$281K +$358K +22,963 New
DekaBank Deutsche Girozentrale
121
DekaBank Deutsche Girozentrale
Germany
$275K
Teacher Retirement System of Texas
122
Teacher Retirement System of Texas
Texas
$275K +$179K +11,467 +104%
Verition Fund Management
123
Verition Fund Management
Connecticut
$271K +$345K +22,147 New
HWA
124
HCR Wealth Advisors
California
$269K
CIBC World Market
125
CIBC World Market
Ontario, Canada
$265K -$341K -21,868 -50%

EDIT Hedge Fund Activity: Q3 2022 in Review

264 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2022, worth a combined $591M — up 5.4% from $561M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new EDIT positions and 28 closed out — a net gain of 11 holders — while 73 added to existing stakes and 75 trimmed.

The largest buyer was Millennium Management, adding an estimated $27M. The largest seller was State Street, cutting an estimated $23.9M.

  • 264 institutional investors held Editas Medicine (EDIT) as of Q3 2022, up from 256 in Q2 2022.
  • Funds reported $591M of Editas Medicine stock for Q3 2022, up 5.4% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q3 2022 and 28 closed out, a net change of +11 holders.
  • The largest Editas Medicine buyer in Q3 2022 was Millennium Management, an estimated $27M added.
  • The largest Editas Medicine seller in Q3 2022 was State Street, an estimated $23.9M sold.

Based on aggregated 13F filings for Q3 2022.